TAPI offers customized CDMO Solutions for API development and manufacturing services.
01 1TEVA CZECH INDUSTRIES S.R.O. Opava CZ
02 1Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE
03 1CURIA ITALY S.R.L. Rozzano, Milano IT
01 3Dihydroergotamine mesilate
01 1Germany
02 1Israel
03 1U.S.A
01 2Valid
02 1Withdrawn by Holder
TAPI offers customized CDMO Solutions for API development and manufacturing services.
TAPI offers customized CDMO Solutions for API development and manufacturing services.
Certificate Number : R1-CEP 2005-107 - Rev 02
Status : Valid
Issue Date : 2022-11-07
Type : Chemical
Substance Number : 551
Certificate Number : R1-CEP 2001-268 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2015-11-03
Type : Chemical
Substance Number : 551
Certificate Number : R1-CEP 2000-183 - Rev 08
Status : Valid
Issue Date : 2023-03-08
Type : Chemical
Substance Number : 551
A Dihydroergotamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotamine, including repackagers and relabelers. The FDA regulates Dihydroergotamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergotamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergotamine supplier is an individual or a company that provides Dihydroergotamine active pharmaceutical ingredient (API) or Dihydroergotamine finished formulations upon request. The Dihydroergotamine suppliers may include Dihydroergotamine API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergotamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydroergotamine CEP of the European Pharmacopoeia monograph is often referred to as a Dihydroergotamine Certificate of Suitability (COS). The purpose of a Dihydroergotamine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dihydroergotamine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dihydroergotamine to their clients by showing that a Dihydroergotamine CEP has been issued for it. The manufacturer submits a Dihydroergotamine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dihydroergotamine CEP holder for the record. Additionally, the data presented in the Dihydroergotamine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dihydroergotamine DMF.
A Dihydroergotamine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dihydroergotamine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dihydroergotamine suppliers with CEP (COS) on PharmaCompass.
We have 3 companies offering Dihydroergotamine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
